Article: Ranbaxy Laboratories Raises Final Year-End Dividend; Profits Cross Rs. 158 crores; Exports at Rs. 412 crores.

NEW DELHI, India--(BUSINESS WIRE)--June 6, 1996--The Board of Directors of Ranbaxy Laboratories Limited (GDR:RBXD-London) at their meeting held today approved the audited accounts for the year ended March 31, 1996 and recommended a final dividend of 35 percent on equity shares (Rs. 3.50 per share) making a total dividend of 55 percent (Rs. 5.50 per share) for the year (1994-95 - Rs. 5 per share). An interim dividend of 20 percent already paid (Rs. 2 per share).

The total dividend distribution for the year at Rs. 23.72 crores, (US approximately $6.8 million), went up by 19 percent over the previous year (Rs. 20 crores).

The Company recorded sales of Rs. 876.6 ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!